Inhalants Marijuana Cocaine Tobacco Synthetic Marijuana

Total Page:16

File Type:pdf, Size:1020Kb

Inhalants Marijuana Cocaine Tobacco Synthetic Marijuana Inhalants Marijuana Cocaine Tobacco Synthetic Marijuana Product Names Organic solvents, nitrous oxide, Delta­9­tetrahydrocannabinol, Cannabis Cocaine, crack cocaine Cigarettes, cigars, chewing Cannabinoids, cathinones ​ nitrites, aerosols, airplane glue, nail sativa, marijuana, hashish, hashish oil tobacco, e­cigarettes polish remover, lighter fluid, gasoline, paints, hair spray Street Names Glue, Kick, Bang, Sniff, Fuff, Weed, Pot, Grass, Reefer, Mary Jane, Joint, Cocaine: Coke, Snow, Blow, Toot, Cancer Sticks, Bidis Cannabinoids: K2, Fake ​ ​ Poppers, Whippets, Texas Shoeshine, Roach, Nail, Blunt, Herb, Sinsemilla, Nose Candy, Flake, Dust, Sneeze (flavored, hand­rolled weed, Yucatan Fire, Skunk, Poppers, Laughing Gas, Rush Smoke, Skunk, Boom, Gangster, Kiff, Crack cocaine: Crack, Rock, Base, cigarettes), Gloves, Chew, Moon Rocks, Blaz, Red X ​ Chronic, Ganja, Super Skunk, Purple Haze, Sugar Block, Rox/Roxann Smoke, Bone, Butt, Coffin Dawn, Bilss, Black Mamba, Dope, Nederweed (Cigar into which Nail Bombay Blue, Genie, Zoh, marijuana is rolled) Herbal incense, Potpourri Cathinones: Bath salts, Purple wave, White Dust, Ocean Burst, Flakka, Gravel, Spice Symptoms of Slurred speech, incoordination, Mood swings, euphoria, slow thinking and Excitability, euphoria, talkativeness, Smelly hair, clothes, and Elevated mood, relaxation, Use nausea, vomiting, slowed breathing reflexes, dilated pupils, increased appetite, anxiety, increased pulse rate, dilated breath; yellowing of teeth; altered perception, anxiety, dryness of mouth, increased pulse rate, pupils, paranoia, agitation, coughs; increased asthma paranoia, hallucinations, delusions, hallucinations hallucinations attacks; shortness of breath rapid heart rate, vomiting, and poorer athletic agitation, confusion performance. After only a few weeks, users of spit tobacco can develop cracked lips, white spots, sores and bleeding in the mouth Potential Brain damage; pains in chest muscles Amotivational syndrome, memory High risk for addiction, violent Addiction; respiratory High blood pressure, reduced Consequences and joints; heart trouble; severe impairment, weight gain, increased risk for behavior, hallucinations, cocaine problems such as blood supply to the heart depression; toxic psychosis; nerve cancer, lower sperm counts and lower psychosis, eating or sleeping emphysema and chronic (myocardial ischemia), heart damage; fatigue; loss of appetite; testosterone levels for men, increased risk of disorders, impaired sexual bronchitis; heart and attacks, withdrawal, addiction bronchial tube spasm; sores on nose infertility for women, psychological performance, ongoing respiratory cardiovascular disease; or mouth; nose bleeds; diarrhea; dependence requiring more of the drug to get problems, death from cardiac arrest or cancer of the lung, larynx, nausea; bizarre or reckless behavior; the same effect. May affect key respiratory arrest esophagus, bladder, sudden death; suffocation developmental skills pancreas, kidney and mouth Route of Sniffed Ingested and smoked Sniffed and smoked Smoked or ingested orally Smoked or ingested (infusing Administration (chew or spit tobacco) in liquid) Medical Use Nitrous oxide only, for anesthesia Pain relief None None None Legal Status Most products available in retail Illegal federally but legal recreationally in Illegal Illegal under 19 in Alabama, Illegal in all 50 states stores WA, AK, CO, OR and medicinally in ME, Alaska, New Jersey and NH, VT, NY, MA, CT, RI, NJ, DE, MD, Utah. Illegal under 18 in all. MI, IL, MN, MT, CA, NV, AZ, NM .
Recommended publications
  • Clearing the Smoke on Cannabis: Regular Use and Cognitive Functioning
    6 Clearing the Smoke on Cannabis Regular Use and Cognitive Functioning Robert Gabrys, Ph.D., Research and Policy Analyst, CCSA Amy Porath, Ph.D., Director, Research, CCSA Key Points • Regular use refers to weekly or more frequent cannabis use over a period of months to years. Regular cannabis use is associated with mild cognitive difficulties, which are typically not apparent following about one month of abstinence. Heavy (daily) and long-term cannabis use is related to more This is the first in a series of reports noticeable cognitive impairment. that reviews the effects of cannabis • Cannabis use beginning prior to the age of 16 or 17 is one of the strongest use on various aspects of human predictors of cognitive impairment. However, it is unclear which comes functioning and development. This first — whether cognitive impairment leads to early onset cannabis use or report on the effects of chronic whether beginning cannabis use early in life causes a progressive decline in cannabis use on cognitive functioning cognitive abilities. provides an update of a previous report • Regular cannabis use is associated with altered brain structure and function. with new research findings that validate Once again, it is currently unclear whether chronic cannabis exposure and extend our current understanding directly leads to brain changes or whether differences in brain structure of this issue. Other reports in this precede the onset of chronic cannabis use. series address the link between chronic • Individuals with reduced executive function and maladaptive (risky and cannabis use and mental health, the impulsive) decision making are more likely to develop problematic cannabis use and cannabis use disorder.
    [Show full text]
  • EL PASO INTELLIGENCE CENTER DRUG TREND Synthetic Stimulants Marketed As Bath Salts
    LAW ENFORCEMENT SENSITIVE EPIC Tactical Intelligence Bulletins EL PASO INTELLIGENCE CENTER DRUG TREND TACTICAL INTELLIGENCE BULLETIN EB11-16 ● Synthetic Stimulants Marketed as Bath Salts ● March 8, 2011 This document is the property of the Drug Enforcement Administration (DEA) and is marked Law Enforcement Sensitive (LES). Further dissemination of this document is strictly forbidden except to other law enforcement agencies for criminal law enforcement purposes. The following information must be handled and protected accordingly. Summary Across the United States, synthetic stimulants that are sold as “bath salts”¹ have become a serious drug abuse threat. These products are produced under a variety of faux brand names, and they are indirectly marketed as legal alternatives to cocaine, amphetamine, and Ecstasy (MDMA or 3,4-Methylenedioxymethamphetamine). Poison control centers nationwide have received hundreds of calls related to the side-effects of, and overdoses from, the use of these potent and unpredictable products. Numerous media reports have cited bath salt stimulant overdose incidents that have resulted in emergency room visits, hospitalizations, and severe psychotic episodes, some of which, have led to violent outbursts, self-inflicted wounds, and even suicides. A number of states have imposed emergency measures to ban bath salt stimulant products (or the chemicals in them) including Florida, Louisiana, North Dakota, and West Virginia; and similar measures are pending in Hawaii, Kentucky, Michigan, and Mississippi. A prominent U.S.
    [Show full text]
  • Marijuana Legalization and Pretextual Stops
    Marijuana Legalization and Pretextual Stops Alex Kreit* TABLE OF CONTENTS INTRODUCTION ................................................................................... 741 I. HOW PROHIBITION INCENTIVIZES PRETEXTUAL STOPS AND PROFILING ................................................................................ 745 A. The Drug War and Pretextual Stops .................................. 745 B. Marijuana Prohibition and Pretextual Stops ...................... 750 C. Racial Disparities and Pretextual Stops.............................. 754 II. THE POTENTIAL IMPACT OF MARIJUANA LEGALIZATION ON PRETEXTUAL STOPS ................................................................... 757 A. Medical Marijuana ............................................................ 760 B. Decriminalization .............................................................. 764 C. Legalization....................................................................... 768 CONCLUSION....................................................................................... 772 INTRODUCTION Ever since California legalized medical marijuana in 1996,1 judges, lawmakers, and researchers have been contending with a wide range of difficult legal problems.2 Today, with medical marijuana legal in * Copyright © 2016 Alex Kreit. Visiting Professor, Boston College Law School (Fall 2016); Associate Professor and Co-Director, Center for Criminal Law and Policy, Thomas Jefferson School of Law. I thank the UC Davis Law Review editors for inviting me to participate in this symposium and
    [Show full text]
  • 9-THC Disrupts Gamma (Γ)&Ndash;Band Neural
    UCSF UC San Francisco Previously Published Works Title Δ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans Permalink https://escholarship.org/uc/item/6ms753gw Journal Neuropsychopharmacology, 40(9) ISSN 0893-133X Authors Cortes-Briones, J Skosnik, PD Mathalon, D et al. Publication Date 2015-08-16 DOI 10.1038/npp.2015.53 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Accepted Article Preview: Published ahead of advance online publication D9-THC Disrupts Gamma (c)–Band Neural Oscillations in Neuropsychopharmacology www.neuropsychopharmacology.org Humans Jose Cortes-Briones, Patrick D Skosnik, Daniel Mathalon, Methylphenidate modifies the motion of the circadian clock Lamotrigine in mood disorders and cocaine dependence John Cahill, Brian Pittman, Ashley Williams, R Andrew Cortical glutamate in postpartum depression Sewell, Mohini Ranganathan, Brian Roach, Judith Ford, Deepak Cyril D’Souza Cite this article as: Jose Cortes-Briones, Patrick D Skosnik, Daniel Mathalon, John Cahill, Brian Pittman, Ashley Williams, R Andrew Sewell, Mohini Ranganathan, Brian Roach, Judith Ford, Deepak Cyril D’Souza, D9-THC Disrupts Gamma (g)–Band Neural Oscillations in Humans, Neuropsychopharma- cology accepted article preview 24 February 2015; doi: 10.1038/npp.2015.53. This is a PDF file of an unedited peer-reviewed manuscript that has been accepted for publication. NPG are providing this early version of the manuscript as a service to our customers. The manuscript will undergo copyediting, typesetting and a proof review before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers apply.
    [Show full text]
  • The Nursing Implications of Bath Salts Abuse: a Learning Tool and Curriculum for Emergency
    James Madison University JMU Scholarly Commons Senior Honors Projects, 2010-current Honors College Spring 2014 The ursinn g implications of bath salts abuse: A learning tool and curriculum for emergency department nurses Molly Ann Brennan James Madison University Follow this and additional works at: https://commons.lib.jmu.edu/honors201019 Recommended Citation Brennan, Molly Ann, "The urn sing implications of bath salts abuse: A learning tool and curriculum for emergency department nurses" (2014). Senior Honors Projects, 2010-current. 390. https://commons.lib.jmu.edu/honors201019/390 This Thesis is brought to you for free and open access by the Honors College at JMU Scholarly Commons. It has been accepted for inclusion in Senior Honors Projects, 2010-current by an authorized administrator of JMU Scholarly Commons. For more information, please contact [email protected]. The Nursing Implications of Bath Salts Abuse: A Learning Tool and Curriculum for Emergency Department Nurses _______________________ A Project Presented to the Faculty of the Undergraduate College of Health and Behavioral Studies James Madison University _______________________ in Partial Fulfillment of the Requirements for the Degree of Bachelor of Science in Nursing _______________________ by Molly Ann Brennan May, 2014 Accepted by the faculty of the Department of Nursing, James Madison University, in partial fulfillment of the requirements for the Degree of Bachelor of Science in Nursing. FACULTY COMMITTEE: HONORS PROGRAM APPROVAL: Project Advisor: Annie Horigan, Ph.D.,
    [Show full text]
  • Medical Cannabis Q&A
    Medical Cannabis Q&A 1. What is medical cannabis? The term “medical cannabis” is used to describe products derived from the whole cannabis plant or its extracts containing a variety of active cannabinoids and terpenes, which patients take for medical reasons, after interacting with and obtaining authorization from their health care practitioner. 2. What are the main active ingredients? The chemical ingredients of cannabis are called cannabinoids. The two main therapeutic ones are: THC:CBD a. Tetrahydrocannabinol (THC) is a partial agonist of CB1 and CB2 receptors. It is psychoactive and produces the euphoric effect. Each cannabis product will contain THC and CBD, however b. Cannabidiol (CBD) has a weak affinity for CB1 and CB2 receptors and appears the THC: CBD ratio will differ to exert its activity by enhancing the positive effects of the body’s endogenous depending on the product. cannabinoids. 3. Why do patients take it? Medical cannabis may be used to alleviate symptoms for a variety of conditions. It has most commonly been used in neuropathic pain and other chronic pain conditions. There is limited, but developing clinical evidence surrounding its safety and efficacy, and it does not currently have an approved Health Canada indication. 4. How do patients take it? Cannabis can be smoked, vaporized, taken orally, sublingually, topically or rectally. Different routes of administration will result in different pharmacokinetic and pharmacodynamic properties of the drug. 5. Is it possible to develop dependence on medical cannabis? Yes, abrupt discontinuation after long-term use may result in withdrawal symptoms. Additionally, chronic use may result in psychological dependence.
    [Show full text]
  • Concurrent Alcohol and Tobacco Dependence
    Concurrent Alcohol and Tobacco Dependence Mechanisms and Treatment David J. Drobes, Ph.D. People who drink alcohol often also smoke and vice versa. Several mechanisms may contribute to concurrent alcohol and tobacco use. These mechanisms include genes that are involved in regulating certain brain chemical systems; neurobiological mechanisms, such as cross-tolerance and cross-sensitization to both drugs; conditioning mechanisms, in which cravings for alcohol or nicotine are elicited by certain environmental cues; and psychosocial factors (e.g., personality characteristics and coexisting psychiatric disorders). Treatment outcomes for patients addicted to both alcohol and nicotine are generally worse than for people addicted to only one drug, and many treatment providers do not promote smoking cessation during alcoholism treatment. Recent findings suggest, however, that concurrent treatment for both addictions may improve treatment outcomes. KEY WORDS: comorbidity; AODD (alcohol and other drug dependence); alcoholic beverage; tobacco in any form; nicotine; smoking; genetic linkage; cross-tolerance; AOD (alcohol and other drug) sensitivity; neurotransmitters; brain reward pathway; cue reactivity; social AODU (AOD use); cessation of AODU; treatment outcome; combined modality therapy; literature review lcohol consumption and tobacco ers who are dependent on nicotine Department of Health and Human use are closely linked behaviors. have a 2.7 times greater risk of becoming Services 1989). The concurrent use of A Thus, not only are people who alcohol dependent than nonsmokers both drugs by pregnant women can drink alcohol more likely to smoke (and (e.g., Breslau 1995). Finally, although also result in more severe prenatal dam- vice versa) but also people who drink the smoking rate in the general popula­ age and neurocognitive deficits in their larger amounts of alcohol tend to smoke tion has gradually declined over the offspring than use of either drug alone more cigarettes.
    [Show full text]
  • Medical Cannabis Dispensing Collectives and Local
    Americans For Safe Access AN ORGANIZATION OF MEDICAL PROFESSIONALS, SCIENTISTS, AND PATIENTS HELPING PATIENTS MEDICAL CANNABIS DISPENSING COLLECTIVES AND LOCAL REGULATION MEDICAL CANNABIS DISPENSING COLLECTIVES AND LOCAL REGULATION February 2011 EXECUTIVE SUMMARY Introduction ................................................................................................................261 OVERVIEW About this Report.......................................................................................................262 About Americans for Safe Access..............................................................................262 The National Political Landscape...............................................................................262 History of Medical Cannabis in California ................................................................263 What is a Medical Cannabis Dispensing Collective? ................................................263 Rationale for Medical Cannabis Dispensing Collectives ..........................................264 Medical Cannabis Dispensing Collectives are Legal Under State Law....................264 Why Patients Need Convenient Dispensaries ...........................................................264 What Communities are Doing to Help Patients.......................................................265 IMPACT OF DISPENSARIES AND REGULATIONS ON COMMUNITIES Dispensaries Reduce Crime and Improve Public Safety ...........................................266 Why Diversion of Medical Cannabis is Typically
    [Show full text]
  • 119747NCJRS.Pdf
    If you have issues viewing or accessing this file contact us at NCJRS.gov. ,.., , ! FF II tr .... II DIVISION OF NARCOTIC DRUGS Vienna BULLETIN ON NARCOTICS Volume XXXVII, No.4 October-December 1985 Special issue on cannabis 119740- U.S. Department of Justice 119748 National Institute of Justice This document has been reproduced exactly as received from thp. person or organization originating it. Points of view or opinions stated in this document are those of the authors and do not necessarily represent the official position or policies of the National Institute of Justice. Permission to reproduce this copyrighted material has been granted bUN lie. j J{!t( ./,(/ /).f ( Ne.JI/ V (J «k I to the National Criminal JusticeI Reference Service• (NCJRS). Further reproduction outside of the NCJRS system requires permis­ sion of the copyright owner. UNITED NATIONS New York, 1985 CONTENTS Page Editorial note ............................................ , . 1 [An update on cannabis research 0 - by S. Husatrf and I. Khan ............. /.1 . .cr. !. ~. 3 (Critique of a study on ganja in Jamaica by G. G. Nahas ........................ I.~.~ .~<fl.... .. 15 Alteration of glucose metabolism in liver by acute administration of cannabis ~ by P. Sanz, C. Rodrfguez-Vicente and M. Repetto. .. 31 [Illicit traffic and abuse of cannabis in Canada. / I q 7 tr ~ by R. T. Stamler, R. C. Fahlman and H. Vlgeant . .. 37 rCannabis use among youth in the Netherlands 1 . '( I l 'fJ l by G. Sylbmg. and J. M. G. .Pe/soon . ................'1 ....... 51 [yariations of tetrahydrocannabinol content in cannabis plants to distinguish the fibre-type from drug-type plants by U.
    [Show full text]
  • Compendium of Drug Abuse Jargon
    Compendium of Drug Abuse Jargon Ronald P. Evens, PharmD William Clementi, BS (Pharm) San Antonio and Austin, Texas Drug abuse slang is an originative and a protean language, which poses the problem of identification and definition of terms. This compilation of nomenclature provides an extensive list to serve as a resource for the busy family physician, who frequently deals with drug abuse problems. Despite efforts by the government encompassing the following abuse The list on the following pages is and in the private sector to identify agents: alcohol, glue, hallucinogens, organized in alphabetical sequence drug abuse problems and collate the narcotics, sedative-hypnotics, and according to the drug abuse term. terminology of the “drug culture,” the stimulants; and the street slang em­ resultant lists of nomenclature usually ployed in association with their distri­ References describe only the “top 100 or 50” bution and administration, and 1. Konner DD, Rubin I: The pharma­ terms. This severely limits their useful­ reactions to them. cist's drug abuse manual. Pharmacy Times 39:35-37, 1973 ness as a resource tool because a The difficulty in comprehension of 2. Narcotics Identification Guide. significant proportion of the terms are this specialized lingo is primarily due Richmond, Va, Jump Street, The Drug Treatment Program of the Medical College already familiar to practitioners while to its protean nature and the continual of Virginia, 1970 generation of new terms. Different 3. Some Substances Used for Non- a vastly greater number of terms in use prescribed Drugging Effects. Washington, do not appear on the lists at all. subpopulations in the drug abuse cul­ DC, Pharmaceutical Manufacturers Associa­ tion, January, 1973 Therefore, we have accumulated and ture use dissimilar, changeable subsets 4.
    [Show full text]
  • City of Santa Monica Policy on Alcohol Use and Controlled Substances for Certain Holders of Commercial Driver's Licenses
    REVISED/ISSUED NOV. 2009 CITY OF SANTA MONICA POLICY ON ALCOHOL USE AND CONTROLLED SUBSTANCES FOR CERTAIN HOLDERS OF COMMERCIAL DRIVER’S LICENSES SECTION CONTENTS Subpart A – General Page 3 Purpose Scope Definitions Responsibilities Requirement for Notice Employee admission of alcohol and controlled substance abuse Subpart B – Prohibitions Page 9 Alcohol Concentrations On-Duty-Use Pre-Duty Use Use following an accident Refusal to Submit to a required alcohol or controlled substance test Controlled Substance Use Controlled Substances Testing Subpart C – Tests Required Page 10 Pre-employment Testing Post-Accident Testing Random Testing Reasonable Suspicion Testing Return-to-Duty Testing Follow-up Testing Mandatory Direct Observation Collection Procedures Bi-Annual Medical Certificate Renewals 1 Subpart D – Handling of Tests Results, Records, Retention, and Confidentiality Page 17 Test Result Protocol, Records Retention, Types of Records, Confidentiality Reporting of Results in a Management Information System Access to facilities and records Medical Review Officer Responsibilities Subpart E – Consequences of Positive Test Results Page 21 Removal from Safety Sensitive Functions Last Chance Agreement Other Disciplinary Action Subpart F – Training of Drivers and Supervisors Page 22 Appendices A. Job classifications affected by this policy Page 23 B. DOT‟s Direct Observation Procedures Page 24 C. Alcohol and Controlled Substances fact sheets Page 25 2 SUBPART A – GENERAL PURPOSE The purpose of this policy is to protect employees and the public in complying with Federal Motor Carrier Safety Administration laws (49 CFR Parts 40 and 382), the California Drug-Free Workplace Act of 1991, and the City of Santa Monica Municipal Code Section 2.04.420(e) which prohibits employees from reporting for duty or being on duty while under the influence of alcohol or controlled substances; and to establish programs designed to help prevent accidents and injuries resulting from the misuse of alcohol or use of controlled substances by City drivers of commercial motor vehicles.
    [Show full text]
  • Personal Use Cannabis Rules Special Adopted New Rules: N.J.A.C
    NEW JERSEY CANNABIS REGULATORY COMMISSION Personal Use Cannabis Rules Special Adopted New Rules: N.J.A.C. 17:30 Adopted: August 19, 2021 by New Jersey Cannabis Regulatory Commission, Dianna Houenou, Chair. Filed: August 19, 2021 Authority: N.J.S.A. 24:6I-31 et seq. Effective Date: August 19, 2021 Expiration Date: August 19, 2022 This rule may be viewed or downloaded from the Commission’s website at nj.gov/cannabis. These rules are adopted pursuant to N.J.S.A. 24:6I-34(d)1a of the New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act, N.J.S.A. 24:6I- 31 et seq., and became effective upon acceptance for filing by the Office of Administrative Law. The specially adopted new rules shall be effective for a period not to exceed one year from the date of filing of the new rules, that is, until August 19, 2022. The Commission has provided this special adoption to the Attorney General, State Treasurer, Commissioner of Health, and Commissioner of Banking and Insurance for a consultation period, after which the Commission anticipates filing a proposal to readopt these rules with amendments reflecting the results of that consultation. In accordance with N.J.S.A. 24:6I-34(d)1b the rules, as readopted, will become effective upon acceptance for filing by the Office of Administrative Law if filed on or before the expiration date of the rules published herein. The adopted amendments will be effective upon publication in the New Jersey Register. Federal Standards Analysis The Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act obliges the Cannabis Regulatory Commission to promulgate rules necessary or proper to enable it to carry out the Commission’s duties, functions, and powers with respect to overseeing the development, regulation, and enforcement of activities associated with the personal use of cannabis pursuant to P.L.2021, c.16.
    [Show full text]